HR and cancer: Hormone receptor (HR)-positive and human epidermal growth factor receptor-2 (HER2)-negative (HR+/HER2−) breast cancer is one of the most commonly diagnosed cancers in women and generally has a favorable prognosis compared to other subtypes of breast cancer [1].